Government Report Outlines Costs, Savings Of Major Regs
Executive Summary
The US HHS was responsible for the most major regulations over the last few years of any agency, an OMB report shows.
You may also be interested in...
Consent Requirement Change Could Be Boon For Minimal-Risk Studies
US FDA has issued a temporary guidance to allow researchers to conduct "minimal-risk" clinical studies without consent and harmonize the agency's policy with the federal Common Rule for human subject research. The guideline implements a provision in the 21st Century Cures Act.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Implant
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.